CD274 and neoplasm: In addition to, subgroup analysis showed GC patients with deeper tumor infiltration, positive lymph-node metastasis, positive venous invasion, EBV+, MSI-H are more likely to expression PD-L1, suggesting that GC patients specifically with EBV+ and MSI-H may be prime candidates for PD-1 directed therapy.